UCLTF Showcase 2022: Leigh Brody, Investor with UCL Technology Fund

[](https://www.youtube.com/watch?v=VIDEO_ID)

Welcome to the UCLTF Showcase 2022 Panel Discussion on the Life Science stage, chaired by Leigh Brody. In this video, an all-female panel delves into the intriguing question, ‘What does ‘exit’ actually mean in Biotech VC and how is this changing?’ Gain valuable insights from industry experts Cassie Doherty (Parkwalk Advisors), Clare Terlouw (LifeArc), and Mary Canning (Epidarex).

Watch the highlights or catch interviews with the event presenters and hosts in the UCLTF Showcase 2022 playlist on YouTube. Discover the latest developments in life sciences and venture capital: [UCLTF Showcase 2022 Playlist](https://www.youtube.com/playlist?list=PL6S_JMTdD0tn76_f9ZjHpifHhK1a76SRv).

To get a more comprehensive understanding of what took place during the event, check out our detailed article on the UCLTF website: [UCL Technology Fund Showcase 2022 Article](https://www.ucltf.co.uk/news/ucl-technology-fund-showcase-2022).

Explore additional resources and business opportunities at UCLTF through our official channels:
– [UCLTF Website](https://www.ucltf.co.uk/)
– [Twitter](https://twitter.com/UCLTF)
– [LinkedIn](https://www.linkedin.com/company/ucl-technology-fund/)

**Keywords/tags**: UCL Technology Fund, UCLTF, AlbionVC, UCL Business, UCL Innovation & Enterprise, Technology Transfer, Tech Transfer, Spinout, Impact, Innovation, Sustainability, Intellectual Property, Venture Capital.

For the complete transcript of this insightful discussion, read on:

“`
[Full Transcript]

Today at our showcase, I had the honor and pleasure of chairing an all-female panel. We discussed exits in BC and biotech, exploring what it truly means and how it is evolving. It was fascinating to gain perspectives from three accomplished women representing different funds and experiences.

We delved into seed investing, series A, which is the primary focus of UCL Technology Fund. Additionally, we explored institutional funds and how investment strategies vary from early-stage proof of concept projects to spin-outs. Our panel also examined the role of exits in the public market space.

As you can see from the turnout and the engagement of the audience, the event was a resounding success. Join us as we unravel the complexities of ‘exit’ in the biotech VC landscape.

“`

Don’t miss out on this informative discussion! Watch now and subscribe for more exclusive content from UCL Technology Fund.


On the Life Science stage, the UCL Technology Fund (UCLTF) Showcase 2022 panel discussion was chaired by Leigh Brody. The all-female panel discussed the question, ‘What does ‘exit’ actually mean in Biotech VC and how is this changing?’ as insights were shared by Cassie Doherty (Parkwalk Advisors), Clare Terlouw (LifeArc), and Mary Canning (Epidarex).

To watch the highlights, or interviews of individuals who presented or hosted the event, visit the UCLTF Showcase 2022 playlist on YouTube: https://www.youtube.com/playlist?list=PL6S_JMTdD0tn76_f9ZjHpifHhK1a76SRv

If you would like to know more about what happened on the day, read more in our article on the UCLTF website: https://www.ucltf.co.uk/news/ucl-technology-fund-showcase-2022

To learn more about UCLTF, or if you are interested in business opportunities arising from the Fund, visit us online:
– UCLTF Website: https://www.ucltf.co.uk/
– Twitter: https://twitter.com/UCLTF
– LinkedIn: https://www.linkedin.com/company/ucl-technology-fund/

#UCLTF22